Structural studies on the folded domain of the human prion protein bound to the Fab fragment of the antibody POM1.

Prion diseases are neurodegenerative diseases characterized by the conversion of the cellular prion protein PrP(c) into a pathogenic isoform PrP(sc). Passive immunization with antiprion monoclonal antibodies can arrest the progression of prion diseases. Here, the crystal structure of the Fab fragment of an antiprion monoclonal antibody, POM1, in complex with human prion protein (huPrP(c)) has been determined to 2.4 Å resolution. The prion epitope of POM1 is in close proximity to the epitope recognized by the purportedly therapeutic antibody fragment ICSM18 Fab in complex with huPrP(c). POM1 Fab forms a 1:1 complex with huPrP(c) and the measured K(d) of 4.5 × 10(-7) M reveals moderately strong binding between them. Structural comparisons have been made among three prion-antibody complexes: POM1 Fab-huPrP(c), ICSM18 Fab-huPrP(c) and VRQ14 Fab-ovPrP(c). The prion epitopes recognized by ICSM18 Fab and VRQ14 Fab are adjacent to a prion glycosylation site, indicating possible steric hindrance and/or an altered binding mode to the glycosylated prion protein in vivo. However, both of the glycosylation sites on huPrP(c) are positioned away from the POM1 Fab binding epitope; thus, the binding mode observed in this crystal structure and the binding affinity measured for this antibody are most likely to be the same as those for the native prion protein in vivo.

[1]  R. Malinow,et al.  The prion protein as a receptor for amyloid-β , 2010, Nature.

[2]  G. J. Raymond,et al.  The most infectious prion protein particles , 2005, Nature.

[3]  P. Zwart,et al.  Towards automated crystallographic structure refinement with phenix.refine , 2012, Acta crystallographica. Section D, Biological crystallography.

[4]  Human Rezaei,et al.  Insight into the PrPC-->PrPSc conversion from the structures of antibody-bound ovine prion scrapie-susceptibility variants. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[5]  J. Collinge.  Prion diseases of humans and animals: their causes and molecular basis. , 2001, Annual review of neuroscience.

[6]  Hironori K. Nakamura,et al.  Variety of Antiprion Compounds Discovered through an In Silico Screen Based on Cellular-Form Prion Protein Structure: Correlation between Antiprion Activity and Binding Affinity , 2008, Antimicrobial Agents and Chemotherapy.

[7]  B. Mumey,et al.  Antigen-antibody interface properties: composition, residue interactions, and features of 53 non-redundant structures. , 2012, Biochimica et biophysica acta.

[8]  S. Simon,et al.  Screening of 145 Anti-PrP Monoclonal Antibodies for Their Capacity to Inhibit PrPSc Replication in Infected Cells* , 2005, Journal of Biological Chemistry.

[9]  B. Volpe,et al.  Cross-Linking Cellular Prion Protein Triggers Neuronal Apoptosis in Vivo , 2004, Science.

[10]  A. Aguzzi,et al.  Mammalian Prion Biology One Century of Evolving Concepts , 2004, Cell.

[11]  J. Collinge,et al.  PrP Antibodies Do Not Trigger Mouse Hippocampal Neuron Apoptosis , 2012, Science.

[12]  S. Hornemann,et al.  De novo generation of a transmissible spongiform encephalopathy by mouse transgenesis , 2009, Proceedings of the National Academy of Sciences.

[13]  Shaoman Yin,et al.  On-column purification and refolding of recombinant bovine prion protein: using its octarepeat sequences as a natural affinity tag. , 2003, Protein expression and purification.

[14]  Alexei Vagin,et al.  Molecular replacement with MOLREP. , 2010, Acta crystallographica. Section D, Biological crystallography.

[15]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[16]  J. Collinge,et al.  Conformational Properties of β-PrP* , 2009, The Journal of Biological Chemistry.

[17]  Heather T. McFarlane,et al.  Atomic structures of amyloid cross-β spines reveal varied steric zippers , 2007, Nature.

[18]  B. Honig,et al.  Classical electrostatics in biology and chemistry. , 1995, Science.

[19]  N. Sinha,et al.  Electrostatics in protein binding and function. , 2002, Current protein & peptide science.

[20]  G. J. Raymond,et al.  Structural organization of brain-derived mammalian prions as probed by hydrogen exchange , 2011, Nature Structural &Molecular Biology.

[21]  A. Aguzzi,et al.  Crystallization and preliminary X-ray diffraction analysis of prion protein bound to the Fab fragment of the POM1 antibody. , 2011, Acta crystallographica. Section F, Structural biology and crystallization communications.

[22]  J. Castilla,et al.  In Vitro Generation of Infectious Scrapie Prions , 2005, Cell.

[23]  A G Leslie,et al.  Biological Crystallography Integration of Macromolecular Diffraction Data , 2022 .

[24]  W. Surewicz,et al.  Conformational diversity in prion protein variants influences intermolecular β‐sheet formation , 2010, The EMBO journal.

[25]  Adel Golovin,et al.  Cation–π interactions in protein–protein interfaces , 2005 .

[26]  J. Collinge,et al.  Monoclonal antibodies inhibit prion replication and delay the development of prion disease , 2003, Nature.

[27]  R. Will.  Prion Related Disorders , 1999, Journal of the Royal College of Physicians of London.

[28]  G. G. Stokes.  "J." , 1890, The New Yale Book of Quotations.

[29]  Witold K. Surewicz,et al.  Crystal structure of the human prion protein reveals a mechanism for oligomerization , 2002, Nature Structural Biology.

[30]  S. Hornemann,et al.  NMR structure of the bovine prion protein isolated from healthy calf brains , 2004, EMBO reports.

[31]  M. Rowan,et al.  Interaction between prion protein and toxic amyloid β assemblies can be therapeutically targeted at multiple sites , 2011, Nature communications.

[32]  Randy J. Read,et al.  Overview of the CCP4 suite and current developments , 2011, Acta crystallographica. Section D, Biological crystallography.

[33]  J. Collinge,et al.  Pharmacological chaperone for the structured domain of human prion protein , 2010, Proceedings of the National Academy of Sciences.

[34]  Robert A. Grothe,et al.  Structure of the cross-β spine of amyloid-like fibrils , 2005, Nature.

[35]  Fred E. Cohen,et al.  Evidence for assembly of prions with left-handed β-helices into trimers , 2004 .

[36]  J. Collinge,et al.  Crystal structure of human prion protein bound to a therapeutic antibody , 2009, Proceedings of the National Academy of Sciences.

[37]  A. Aguzzi,et al.  Supplementary figure legends , 2010 .

[38]  Kevin Cowtan,et al.  research papers Acta Crystallographica Section D Biological , 2005 .

[39]  K Wüthrich,et al.  NMR solution structure of the human prion protein. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[40]  S. Hornemann,et al.  The POM Monoclonals: A Comprehensive Set of Antibodies to Non-Overlapping Prion Protein Epitopes , 2008, PloS one.

[41]  Kazuo Kuwata,et al.  Hot spots in prion protein for pathogenic conversion , 2007, Proceedings of the National Academy of Sciences.